Vitamin D, 25-Hydroxy, Total
Vitamin D is a fat-soluble steroid hormone that occurs in two forms: Vitamin D3 (cholecalciferol) and Vitamin D2 (ergocalciferol). Vitamin D3 is obtained from foods of animal origin and ultraviolet light-stimulated conversion of 7-dehydrocholesterol in the skin. Small amounts of D2 are obtained from foods of plant origin. Both forms are metabolized to their respective 25-OH D forms in the liver. These forms are then metabolised to their respective metabolically active forms by 1-alpha-hydroxylase in the kidney. This occurs under direct regulation by parathyroid hormone (PTH) and ionized calcium levels. In patients without kidneys, 1,25(OH)2D is not detectable. Each form (1,25(OH)2D2 and 1,25(OH)2D3) has essentially the same metabolic activity.
Vitamin D is stored in adipose (fatty) tissue and enters the circulation bound to vitamin D binding protein (VDBP) and albumin. 1,25-dihydroxy vitamin D plays an integral role in calcium regulation and in the maintenance of healthy bone. In addition, it stimulates the absorption of calcium by the intestine and serves to increase calcium and phosphate reabsorption in the kidney. Primary hyperparathyroidism is usually associated with increased plasma 1,25(OH)2D. A deficiency of Vitamin D results in malformation of bone due to mineralization defects, producing rickets in children, and osteomalacia in adults. In hypercalcemic disorders, 25-OH D is useful in disorders associated with decreased PTH levels, or vitamin D overdose (hypervitaminosis D). Because of its long half-life, 25-OH D is considered to be the most reliable measure of overall Vitamin D status. Measurement of 25-OH D is the best indicator of both vitamin D deficiency and toxicity.
- Diagnosis of vitamin D deficiencies or intoxication
- Diagnosis of malabsorption-related vitamin D deficiency
- Rule out vitamin D deficiency as a cause of bone disease
- Differential diagnosis of hypercalcemia, hypocalcemia, and hypercalciuria
- Monitor therapeutic response in patients being treated for vitamin D related disorders
Increased in:
- Patient taking vitamin supplement in higher supplement doses
- Heavy milk drinkers
- Vitamin D intoxication due to higher doses, and sun exposure
- Hyperparathyroidism
Decreased in:
- Dietary deficiency
- Malabsorption
- Lack of sun exposure
- Rickets
- Osteomalacia including tumor-induced
- Biliary and portal cirrhosis
- Chronic Renal failure with azotemia
- Hypoparathyroidism
- Pseudohypoparathyroidism
- Some drugs such as phenytoin, Phenobarbital
- Familial hypophosphatemia (vitamin D-resistant rickets)
- Post-menopausal osteoporosis
- Diabetes mellitus requiring insulin in adolescents
- Severe deficiency: <10ng/mL
- Inadequate: 10-29 ng/mL
- Normal levels: 30-80ng/mL
- Excess: >80ng/mL
- Toxic: >150ng/mL
Serum (SST) or Plasma Heparin (Green).
Stability
- Ambient: 72 hours
- Refrigerated: 28 days
- Frozen: 28 days
- Clin Nephrol. 2005;64:288. [PMID: 16240900]
- Expert Opin Pharmacother. 2008 Jan;9(1):107-18. [PMID: 18076342]
- Altern Med Rev. 2008 Mar;13(1):6-20. [PMID: 18377099]
- Eur J Endocrinol. 2006;155:237. [PMID: 16868136]
- Drug Ther Bull. 2006;44:25. [PMID: 16617932]
- Joint Bone Spine. 2006;73:249. [PMID: 16563839]
- J Endocrinol Invest. 2006;29:511. [PMID: 16840828]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757